SLN 10-Q: SEC filing

Silence Therapeutics plc

Filed with the SEC on Nov 13, 2026 · accession 0001193125-26-458896

SLN filed a 10-Q (quarterly report) with the SEC on Nov 13, 2026. Silence Therapeutics plc filed its quarterly report on Form 10-Q for the period ended September 30, 2026, reporting financial results including collaboration revenue from AstraZeneca and Hansoh agreements, and disclosing an underwritten public offering and an open market sale agreement with…

Summary of the filing

Silence Therapeutics plc filed its quarterly report on Form 10-Q for the period ended September 30, 2026, reporting financial results including collaboration revenue from AstraZeneca and Hansoh agreements, and disclosing an underwritten public offering and an open market sale agreement with Jefferies LLC.

For details, click here →How to read a 10-Q →

Key details

Collaboration partnerAstraZeneca

Collaboration partnerHansoh

Open market sale agreement counterpartyJefferies LLC

✦ Ask GOAX AI about this filing — what it means for SLN, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for SLN?

Click here

Frequently asked questions

What did SLN file with the SEC on Nov 13, 2026?

SLN filed a 10-Q (SEC filing). Silence Therapeutics plc filed its quarterly report on Form 10-Q for the period ended September 30, 2026, reporting financial results including collaboration revenue from AstraZeneca and Hansoh agreements, and disclosing an underwritten public offering and an open market sale agreement with Jefferies LLC.

How do I read a 10-Q?

The quarterly report: unaudited results for the quarter plus management’s comments. Compare revenue, margins and cash flow with the same quarter last year. Check MD&A for guidance changes and what drove the quarter.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 10-Q (quarterly report): The quarterly report: unaudited results for the quarter plus management’s comments.

Other SLN SEC filings

Get alerts when SLN files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days

SLN overview SLN analysis SLN news Latest SEC filings